Cynthia Fourgeux

Dr. Cynthia Fourgeux

Centre Hospitalier Universitaire de Nantes, Nantes, Pays de la Loire, France
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 February 2006 in Journal of Virology
Verified
Journal Article
Open access
PDF file
NPNathalie Parez
Nathalie Parez
CFCynthia Fourgeux
Cynthia Fourgeux
AMAli Mohamed
Ali Mohamed
CDCatherine Dubuquoy
Catherine Dubuquoy
MPMathieu Pillot
Mathieu Pillot
AGAntoine Garbarg-Chenon
Antoine Garbarg-Chenon
To evaluate whether the rectal route of immunization may be used to provide appropriate protection against enteric pathogens such as rotaviruses (RV), we studied the antibody response and the protection induced by rectal immunization of mice with RV virus-like particles (VLP). For this purpose, 6-week-old BALBc mice were rectally immunized twice with RV 8-2/6/7-VLP derived from the bovine RV RF81 strain either alone or combined with various adjuvants including four toxins [cholera toxin (CT) and three attenuated Escherichia coli -derived heat-labile toxins (LTs), LT(R192G), LT(R72), and LT(K63)] and two Toll-like receptor-targeting adjuvants (CpG and resiquimod). Six weeks after the second immunization, mice were challenged with murine RV strain ECw. RV VLP administered alone were not immunogenic and did not protect mice against RV challenge. By contrast, RV VLP combined with any of the toxin adjuvants were immunogenic (mice developed significant titers of anti-RV immunoglobulin A [IgA] in both serum and feces and of anti-RV IgG in serum) and either efficiently induced complete protection of the mice (no detectable fecal virus shedding) or, for LT(K63), reduced the amount of fecal virus shedding after RV challenge. When combined with RV VLP, CpG and resiquimod failed to achieve protection, although CpG efficiently induced an antibody response to RV. These results support the consideration of the rectal route for the development of new immunization strategies against RV infection. Rectal delivery of a VLP-based vaccine might allow the use of adjuvants less toxic than, but as efficient as, CT.

16 November 2022 in Science Advances
Verified
Journal Article
Open access
MDMarion Drouin
Marion Drouin
JSJavier Saenz
Javier Saenz
VGVanessa Gauttier
Vanessa Gauttier
BEBerangere Evrard
Berangere Evrard
GTGeraldine Teppaz
Geraldine Teppaz
ECElise Chiffoleau
Elise Chiffoleau
Tumors exploit numerous immune checkpoints, including those deployed by myeloid cells to curtail antitumor immunity. Here, we show that the C-type lectin receptor CLEC-1 expressed by myeloid cells senses dead cells killed by programmed necrosis. Moreover, we identified Tripartite Motif Containing 21 (TRIM21) as an endogenous ligand overexpressed in various cancers. We observed that the combination of CLEC-1 blockade with chemotherapy prolonged mouse survival in tumor models. Loss of CLEC-1 reduced the accumulation of immunosuppressive myeloid cells in tumors and invigorated the activation state of dendritic cells (DCs), thereby increasing T cell responses. Mechanistically, we found that the absence of CLEC-1 increased the cross-presentation of dead cell–associated antigens by conventional type-1 DCs. We identified antihuman CLEC-1 antagonist antibodies able to enhance antitumor immunity in CLEC-1 humanized mice. Together, our results demonstrate that CLEC-1 acts as an immune checkpoint in myeloid cells and support CLEC-1 as a novel target for cancer immunotherapy.

19 January 2022 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
SKSébastien Küry
Sébastien Küry
FEFrédéric Ebstein
Frédéric Ebstein
AMAlice Mollé
Alice Mollé
TBThomas Besnard
Thomas Besnard
MLMing-Kang Lee
Ming-Kang Lee
BIBertrand Isidor
Bertrand Isidor

29 January 2025 in Nature Communications
Verified
Journal Article
Open access
PDF file
ACAnaïs Cardon
Anaïs Cardon
TGThomas Guinebretière
Thomas Guinebretière
CDChuang Dong
Chuang Dong
LGLaurine Gil
Laurine Gil
SASakina Ado
Sakina Ado
ARAmédée Renand
Amédée Renand
Autoimmune liver diseases (AILD) involve dysregulated CD4 T cell responses against liver self-antigens, but how these autoreactive T cells relate to liver tissue pathology remains unclear. Here we perform single-cell transcriptomic and T cell receptor analyses of circulating, self-antigen-specific CD4 T cells from patients with AILD and identify a subset of liver-autoreactive CD4 T cells with a distinct B-helper transcriptional profile characterized by PD-1, TIGIT and HLA-DR expression. These cells share clonal relationships with expanded intrahepatic T cells and exhibit transcriptional signatures overlapping with tissue-resident T cells in chronically inflamed environments. Using a mouse model, we demonstrate that, following antigen recognition in the liver, CD4 T cells acquire an exhausted phenotype, play a crucial role in liver damage, and are controlled by immune checkpoint pathways. Our findings thus suggest that circulating autoreactive CD4 T cells in AILD are imprinted by chronic antigen exposure to promote liver inflammation, thereby serving as a potential target for developing biomarkers and therapies for AILD.

15 July 2021 in The Journal of Immunology
Verified
Journal Article
Closed access
PDF file
MLMelanie Lancien
Melanie Lancien
GBGeraldine Bienvenu
Geraldine Bienvenu
SSSonia Salle
Sonia Salle
LGLucile Gueno
Lucile Gueno
MFMagalie Feyeux
Magalie Feyeux
CLCedric Louvet
Cedric Louvet
Intracellular ion fluxes emerge as critical actors of immunoregulation but still remain poorly explored. In this study, we investigated the role of the redundant cation channels TMEM176A and TMEM176B (TMEM176A/B) in retinoic acid–related orphan receptor γt+ cells and conventional dendritic cells (DCs) using germline and conditional double knockout mice. Although Tmem176a/b appeared surprisingly dispensable for the protective function of Th17 and group 3 innate lymphoid cells in the intestinal mucosa, we found that they were required in conventional DCs for optimal Ag processing and presentation to CD4+ T cells. Using a real-time imaging method, we show that TMEM176A/B accumulate in dynamic post-Golgi vesicles preferentially linked to the late endolysosomal system and strongly colocalize with HLA-DM. Taken together, our results suggest that TMEM176A/B ion channels play a direct role in the MHC class II compartment of DCs for the fine regulation of Ag presentation and naive CD4+ T cell priming. Key Points Germline and conditional double KO mice target Tmem176a and Tmem176b. Tmem176a/b appear dispensable in RORγt+ cells. Tmem176a/b are required in DCs for optimal MHC class II–mediated antigen presentation.

30 January 2023 in Life Science Alliance
Verified
Journal Article
Open access
PDF file
NKNGUYEN Ngoc Khanh
NGUYEN Ngoc Khanh
MDMarie-Claire Devilder
Marie-Claire Devilder
LGLaetitia Gautreau-Rolland
Laetitia Gautreau-Rolland
CFCynthia Fourgeux
Cynthia Fourgeux
DSDebajyoti Sinha
Debajyoti Sinha
DMDorian McILROY
Dorian McILROY
The BK polyomavirus (BKPyV) is an opportunistic pathogen, which is only pathogenic in immunosuppressed individuals, such as kidney transplant recipients, in whom BKPyV can cause significant morbidity. To identify broadly neutralizing antibodies against this virus, we used fluorescence-labeled BKPyV virus-like particles to sort BKPyV-specific B cells from the PBMC of KTx recipients, then single-cell RNAseq to obtain paired heavy- and light-chain antibody sequences from 2,106 sorted B cells. The BKPyV-specific repertoire was highly diverse in terms of both V-gene usage and clonotype diversity and included most of the IgM B cells, including many with extensive somatic hypermutation. In two patients where sufficient data were available, IgM B cells in the BKPyV-specific dataset had significant differences in V-gene usage compared with IgG B cells from the same patient. CDR3 sequence–based clustering allowed us to identify and characterize three broadly neutralizing “41F17-like” clonotypes that were predominantly IgG, suggesting that some specific BKPyV capsid epitopes are preferentially targeted by IgG.